webinar register page

Webinar banner
IMV KOL Webcast on Ovarian Cancer treatment landscape and data highlights from the Phase 2 trial with novel T Cell Therapy
Please join us for the IMV KOL Webcast on Ovarian Cancer treatment landscape and data highlights from the Phase 2 trial with novel T Cell Therapy featuring Oliver Dorigo, MD, PhD and Jeannine Villella, DO, FACOG, FACS who will discuss the treatment options in ovarian cancer and competitive landscape within the disease state. A Q&A session will follow the formal presentations.

Dec 3, 2020 08:00 AM in Eastern Time (US and Canada)

* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register

Speakers

Oliver Dorigo, MD, PhD
@Stanford University
r. Oliver Dorigo is the director and associate professor of the division of gynecologic oncology and the director of the gynecologic clinical care program at the Women’s Cancer Center at Stanford University. He is also director of the Mary Lake Polan Gynecologic Oncology Research Laboratory. Dr. Dorigo received his MD from the University of Heidelberg Medical School in Germany.
Jeannine Villella, DO, FACOG, FACS
@Winthrop University Hospital
Jeannine Villella, DO, FACOG, FACS Dr. Jeannine Villella obtained her medical degree from New York College of Osteopathic Medicine in Old Westbury, New York and completed her residency training in Obstetrics and Gynecology at Winthrop University Hospital. Thereafter, Dr. Villella was granted a 2-year Henrietta Milstein Fellowship at Columbia University College of Physicians & Surgeons. As part of the division of gynecologic oncology, she performed research in the role of angiogenesis in ovarian cancer and was involved in the care of gynecologic oncology patients.